Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cisplatin Ototoxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Post-approval studies (Phase 4)Study completedNCT01372904
What this trial is testing

Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment

Who this might be right for
Cisplatin Ototoxicity
Meir Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT03480971
What this trial is testing

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Who this might be right for
MucositisNephrotoxicityOtotoxicity
Matrix Biomed, Inc. 120
Testing effectiveness (Phase 2)Looking for participantsNCT05129748
What this trial is testing

Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 92
Testing effectiveness (Phase 2)Study completedNCT04541355
What this trial is testing

Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin

Who this might be right for
Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Advanced Head and Neck Squamous Cell Carcinoma+26 more
Hyunseok Kang, MD
Not applicableStudy completedNCT02099786
What this trial is testing

Randomized Trial Comparison of Ototoxicity Monitoring Programs

Who this might be right for
Cisplatin OtotoxicityHearing Loss
VA Office of Research and Development 47
Testing effectiveness (Phase 2)Ended earlyNCT02281006
What this trial is testing

Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity

Who this might be right for
DDPHead and Neck CancerAdverse Effect
CHU de Quebec-Universite Laval 13
Testing effectiveness (Phase 2)WithdrawnNCT01451853
What this trial is testing

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Who this might be right for
Lung CancerHead and Neck CancerHearing Loss+3 more
Sound Pharmaceuticals, Incorporated
Testing effectiveness (Phase 2)Looking for participantsNCT07364747
What this trial is testing

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Who this might be right for
Cisplatin-induced OtotoxicitySensorineural Hearing LossOtotoxicity+1 more
Siriraj Hospital 40
Not applicableLooking for participantsNCT05946577
What this trial is testing

Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study

Who this might be right for
Head CancerNeck Cancer
Assistance Publique - Hôpitaux de Paris 140
Large-scale testing (Phase 3)Study completedNCT00716976
What this trial is testing

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Who this might be right for
Brain TumorCentral Nervous System TumorChildhood Germ Cell Tumor+6 more
Children's Oncology Group 131
Early research (Phase 1)Study completedNCT04262336
What this trial is testing

Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment

Who this might be right for
Ototoxicity
Decibel Therapeutics 22
Testing effectiveness (Phase 2)Study completedNCT01848457
What this trial is testing

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Who this might be right for
OsteosarcomaNephrotoxicityOtotoxicity
Children's Hospital of Philadelphia 13
Not applicableLooking for participantsNCT06662058
What this trial is testing

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Who this might be right for
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Cutaneous Squamous Cell Carcinoma of the Head and NeckHead and Neck Carcinoma of Unknown Primary+30 more
Emory University 118
Not applicableNot Yet RecruitingNCT07622407
What this trial is testing

Maximizing Quality of Life After Cancer Through Rehabilitation

Who this might be right for
Head and Neck CancerHearing LossTinnitus+1 more
VA Office of Research and Development 74
Testing effectiveness (Phase 2)UnknownNCT04291209
What this trial is testing

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Who this might be right for
Ototoxic Hearing Loss
Sunnybrook Health Sciences Centre 80
Testing effectiveness (Phase 2)Study completedNCT06553157
What this trial is testing

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Who this might be right for
Solid TumorsOtotoxicity
Minia University 56
Testing effectiveness (Phase 2)Study completedNCT05628233
What this trial is testing

SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease

Who this might be right for
Hearing Loss Ototoxic
Sensorion 48
16